• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 22
  • 11
  • 8
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

5
21
23
51

PUBLISHED

0
3
3
51

PRODUCT TYPE

44
7

Search "Nutri Pharma ASA" returned 51 results.

Nutri Pharma ASA (NUT) - Financial and Strategic Analysis Review

Nutri Pharma ASA (Nutri Pharma ) is a Norway-based biotechnology company. The company is engaged in the treatment and prevention of lifestyle-related diseases. The company's expertise in soy technology...

September 2010
FROM

Nutri Pharma ASA - Company PicShot - Company PicShot

This Company PicShot is a brief, yet detailed, profile of the chosen company. The PicShot profiles the company in terms of historical background, company overview, business segment analysis, a view...

November 2010
FROM

Bionor Pharma ASA - Product Pipeline Review - 2013

Bionor Pharma ASA – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Bionor Pharma ASA - Product Pipeline Review - 2013” provides data on the Bionor Pharma ASA’s...

April 2013
FROM

Bionor Pharma ASA - Product Pipeline Review - 2012

Bionor Pharma ASA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Bionor Pharma ASA - Product Pipeline Review - 2012” provides data on the Bionor Pharma ASA’s...

September 2012
FROM

Bionor Pharma ASA (BIONOR) - Financial and Strategic SWOT Analysis Review

Bionor Pharma ASA (BIONOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by...

May 2015
FROM

Cervical Cancer - Pipeline Review, H2 2013

Cervical Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Hepatitis C - Pipeline Review, H2 2013

Hepatitis C - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Herpes Infections - Pipeline Review, H2 2012

Herpes Infections – Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Herpes Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline This report...

December 2012
FROM

Uterine Cancer - Pipeline Review, H1 2013

Uterine Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Uterine Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM

Seasonal Influenza - Pipeline Review, H2 2013

Seasonal Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Seasonal Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Gynecological Cancer - Pipeline Review, H1 2013

Gynecological Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gynecological Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM

HIV-1 Infection - Pipeline Review, H2 2013

HIV-1 Infection - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'HIV-1 Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Cervical Cancer - Pipeline Review, H1 2013

Cervical Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM

Influenza - Pipeline Review, H2 2013

Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Herpes Infections - Pipeline Review, H1 2013

Herpes Infections - Pipeline Review, H1 2013 Summary 'Herpes Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

June 2013
FROM

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013', provides an overview of the indication’s...

July 2013
FROM

Hepatitis C - Pipeline Review, H1 2013

Hepatitis C – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM

NeuroSearch A/S

A textual analysis of the financial results for NeuroSearch A/S compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

June 2015
FROM

Aquila

A textual analysis of the financial results for Aquila compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and...

June 2015
FROM

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2013

Cytomegalovirus (HHV-5) Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

February 2013
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG